PRCT
CEO says: I’ll take some of that
When a CEO reaches into their own pocket to buy shares after a brutal selloff, investors usually perk up. In this case, Procept BioRobotics’ top boss bought 23,900 shares at $20.85 each, putting about $498,000 on the line. That’s not a casual lunch-order amount of money — it’s a pretty loud signal that management thinks the market may have gotten ahead of itself.
Why this matters to you
Insider buying doesn’t guarantee a rebound. CEOs can be wrong, stocks can stay moody, and the market loves a dramatic overshoot in both directions. But insider purchases can matter because they often hint at conviction: maybe the business pipeline looks better than the chart does, maybe the decline feels overdone, or maybe management simply thinks the fundamentals are being unfairly punished.
The stock is still the main character
The eyebrow-raiser here is the context: PRCT has fallen 48%. That kind of drop can make even strong companies look like they’ve been run through a car wash. So the buy is less “everything is fixed” and more “someone who knows the company well is willing to bet real money that the story isn’t as broken as the market thinks.”
Big picture: insider buying after a big selloff can be a useful clue, but it’s a clue — not a crystal ball.